mobile.zenopa.com Homepage Homepage
Employment Role Location
Business Sector Advanced
Phone 01494 818 000
Current Jobs

Sales Account Manager
Location: Surrey/SW London

Clinical Sales Specialist
Location: North London and Home Counties

Account Manager, LSMS
Location: North UK

Account Manager LSMS
Location: South UK

Editorial Assistant
Location: Macclesfield

Territory Business Manager
Location: Hampshire

Territory Business Manager
Location: West London

Territory Business Manager
Location: North East

National Sales Manager
Location: National

Territory Business Manager
Location: South West

Senior Medical Writer
Location: Cheshire

Key Account Manager
Location: South West & Wales

Territory Manager - Sports Medicine
Location: Kent

New Business Development Manager
Location: Surrey

Medical Advisor
Location: Berkshire

SHA to lead allergy services improvement

Posted on 01/09/2008 in Medical Government/ NHS related news

The Department of Health has announced the North West Strategic Health Authority (SHA) is to lead improvements in allergy services.

It has been appointed to head up a new drive to improve facilities for individuals affected by allergies.

The SHA will develop a pilot allergy centre which will then be used as a model for similar centres across the UK.

At the centre, the expertise of clinicians with an interest in allergies will be brought together to provide a coordinated and integrated service to patients across primary and secondary care.

Ann Keen, health minister, said: "Allergies affect the lives of millions of people in this country and we are ensuring this important issue gets the recognition it deserves."

She said the decision to appoint a lead SHA in this area marks significant progress.

Allergy UK said it was sure many valuable lessons will be learnt from this pilot, which will result in the development of enhanced services for allergy sufferers across the country.

In June 2006, Allergy Therapeutics presented trial results suggesting a new vaccine could help reduce the symptoms of hayever.

The company argued that Pollinex Quattro, a vaccine injected four times, showed statistically significant benefits compare to placebo.

Other news stories from 01/09/2008

Read more in the Zenopa News Archive

How this news is generated

Joe
Leeds Manager


home | our clients | browse news | browse jobs | links | hotel directory | Valid HTML | copyright © 2010 Zenopa Ltd | terms & conditions of use